PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00053885
Recruitment Status : Completed
First Posted : February 6, 2003
Last Update Posted : July 1, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2005
  Study Completion Date : June 2006
Publications of Results:
Jahan TM, Gu L, Wang X, et al.: Vatalanib (V) for patients with previously untreated advanced malignant mesothelioma (MM): A phase II study by the Cancer and Leukemia Group B (CALGB 30107). [Abstract] J Clin Oncol 24 (Suppl 18): A-7081, 2006.

Publications automatically indexed to this study by Identifier (NCT Number):